A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

NCT06999733 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurotrophic Keratitis

Interventions

BIOLOGICAL: KB801
DRUG: Placebo

Sponsor

Krystal Biotech, Inc.